BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28060184)

  • 21. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus.
    Tanaka M
    Digestion; 2014; 90(4):265-72. PubMed ID: 25591885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
    Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
    J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of extrapancreatic neoplasms in intraductal papillary mucinous neoplasm of the pancreas: implications for management.
    Reid-Lombardo KM; Mathis KL; Wood CM; Harmsen WS; Sarr MG
    Ann Surg; 2010 Jan; 251(1):64-9. PubMed ID: 19858708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas.
    Mimura T; Masuda A; Matsumoto I; Shiomi H; Yoshida S; Sugimoto M; Sanuki T; Yoshida M; Fujita T; Kutsumi H; Ku Y; Azuma T
    J Clin Gastroenterol; 2010 Oct; 44(9):e224-9. PubMed ID: 20453661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate?
    Salvia R; Crippa S; Falconi M; Bassi C; Guarise A; Scarpa A; Pederzoli P
    Gut; 2007 Aug; 56(8):1086-90. PubMed ID: 17127707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic ultrasound-guided fine-needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases.
    Salla C; Chatzipantelis P; Konstantinou P; Karoumpalis I; Sakellariou S; Pantazopoulou A; Manika Z
    JOP; 2007 Nov; 8(6):715-24. PubMed ID: 17993724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms.
    Wiesenauer CA; Schmidt CM; Cummings OW; Yiannoutsos CT; Howard TJ; Wiebke EA; Goulet RJ; McHenry L; Sherman S; Lehman GA; Cramer H; Madura JA
    Arch Surg; 2003 Jun; 138(6):610-7; discussion 617-8. PubMed ID: 12799331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms.
    Yoon WJ; Ryu JK; Lee JK; Woo SM; Lee SH; Park JK; Kim YT; Yoon YB
    Ann Surg Oncol; 2008 Nov; 15(11):3193-8. PubMed ID: 18784959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study.
    Capurso G; Boccia S; Salvia R; Del Chiaro M; Frulloni L; Arcidiacono PG; Zerbi A; Manta R; Fabbri C; Ventrucci M; Tarantino I; Piciucchi M; Carnuccio A; Boggi U; Leoncini E; Costamagna G; Delle Fave G; Pezzilli R; Bassi C; Larghi A; ;
    Am J Gastroenterol; 2013 Jun; 108(6):1003-9. PubMed ID: 23458848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopic biliary stenting successfully managed mucus obstructive jaundice in intraductal papillary mucinous carcinoma.
    Hashimoto Y; Ose H; Ogawa O; Yoshikumi H; Maruoka N; Yoshiba M
    Endoscopy; 2010; 42 Suppl 2():E63-4. PubMed ID: 20195967
    [No Abstract]   [Full Text] [Related]  

  • 31. [Overview of revised international consensus guidelines 2012 for the management of IPMN and MCN].
    Tamura K; Ohtsuka T; Tanaka M
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():400-4. PubMed ID: 25857056
    [No Abstract]   [Full Text] [Related]  

  • 32. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
    Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
    Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraductal papillary mucinous neoplasms of the pancreas: making a disposition using the natural history.
    Traverso LW; Moriya T; Hashimoto Y
    Curr Gastroenterol Rep; 2012 Apr; 14(2):106-11. PubMed ID: 22278702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraductal papillary mucinous neoplasms of the pancreas: is the puzzle solved?
    Balsarkar D; Takahata S; Tanaka M
    Indian J Gastroenterol; 2013 Jul; 32(4):213-21. PubMed ID: 23512214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the 2012 International Consensus Guidelines Using Computed Tomography and Magnetic Resonance Imaging: Branch Duct and Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Seo N; Byun JH; Kim JH; Kim HJ; Lee SS; Song KB; Kim SC; Han DJ; Hong SM; Lee MG
    Ann Surg; 2016 Mar; 263(3):557-64. PubMed ID: 25822687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The natural history of main duct-involved, mixed-type intraductal papillary mucinous neoplasm: parameters predictive of progression.
    Roch AM; Ceppa EP; Al-Haddad MA; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Ann Surg; 2014 Oct; 260(4):680-8; discussion 688-90. PubMed ID: 25203885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
    J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
    Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
    Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas.
    Ingkakul T; Sadakari Y; Ienaga J; Satoh N; Takahata S; Tanaka M
    Ann Surg; 2010 Jan; 251(1):70-5. PubMed ID: 20009749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can long-term follow-up strategies be determined using a nomogram-based prediction model of malignancy among intraductal papillary mucinous neoplasms of the pancreas?
    Hijioka S; Shimizu Y; Mizuno N; Hara K; Imaoka H; Mekky MA; Bhatia V; Nagashio Y; Hasegawa T; Shinagawa A; Sekine M; Tajika M; Tanaka T; Ishihara M; Niwa Y; Yamao K
    Pancreas; 2014 Apr; 43(3):367-72. PubMed ID: 24622065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.